Additional file 2: of Bortezomib enhances radiosensitivity in oral cancer through inducing autophagy-mediated TRAF6 oncoprotein degradation

  • Yuan Hua Wu (Creator)
  • Wei Lei Yang (Contributor)
  • Bour Jr Wang (Contributor)
  • Ya Ling Yeh (Creator)
  • Bu Miin Huang (Contributor)
  • Wun Syuan Wu (Creator)
  • Chiang Shin Liu (Contributor)
  • Li Ching Lin (Contributor)
  • Sheng Yow Ho (Contributor)
  • Hui-Wen Chiu (Creator)
  • Ying Jan Wang (Contributor)



Figure S1. Bortezomib inhibits TRAF6-mediated Akt activation. Figure S2. Combined treatment synergistically inhibits tumorigenesis of human oral cancer cells in vivo. (DOCX 2226Â kb)
Date made available2018

Cite this